Tag: catalent

August 14, 2018

Catalent Completes Tender Offer for All Outstanding Shares of Juniper Pharmaceuticals

Catalent (NYSE:CTLT) the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products,...
July 3, 2018

Catalent Signs Agreement to Acquire Juniper Pharmaceuticals

Catalent (NYSE:CTLT), the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products,...
October 13, 2016

Catalent Announces First Quarter Fiscal Year 2017 Earnings Conference Webcast

The Company’s management will host a webcast to discuss the results at 4:45 p.m. ET on November 7, 2016.
September 14, 2016

Catalent Buys Pharmatek and Lands Spray Drying Technology

The latest M&A news comes from Catalent, a mid cap company that provides drug delivery and development technologies to the...
June 7, 2016

Disruptive Technologies and Emerging Trends Drive Life Science Transformation

If you are interested in more information, please contact Kayla Belcher, Corporate Communications, at kayla.belcher@frost.com. Through growth opportunities, the Life...
March 3, 2016

Biohaven Announces Orphan Drug Designation Request Granted for the Treatment of Spinocerebellar Ataxia

Biohaven Pharmaceutical Holding Company Ltd. announced that the Food and Drug Administration has granted the company's orphan drug designation request...
February 25, 2016

Biohaven Announces Expedited Development Path for BHV-0223 Following Successful Pre-IND Interaction With FDA

Biohaven Pharmaceutical Holding Company Ltd. announced receiving favorable and productive feedback from their Pre-Investigational New Drug Application (PIND) interaction with...